featured
Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Pre-Specified Secondary End Points in ORION 1
Circulation 2018 May 07;[EPub Ahead of Print], KK Ray, RM Stoekenbroek, D Kallend, LA Leiter, U Landmesser, RS Wright, P Wijngaard, JJ KasteleinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.